Cost Analysis and Resource Utilization of Gynecologic Cancer-Related Thoracenteses and Paracenteses - Takeaways - MDSpire

Economic Evaluation and Resource Use in Thoracentesis and Paracentesis for Patients with Gynecologic Cancers

  • By

  • Yingao Zhang

  • Olivia Foy

  • Grace Pipes

  • Margaret I. Liang

  • July 21, 2026

Share

  • 1

    Paracentesis and thoracentesis are common procedures for patients with advanced gynecologic cancers experiencing ascites or pleural effusion.

  • 2

    The study analyzed 216 patients, revealing that 79% of laboratory tests performed on fluid samples were unindicated.

  • 3

    The total cost of unindicated laboratory tests during the study period was $1,129,520.

  • 4

    Nononcology clinicians were more likely to order unindicated tests, particularly in inpatient and emergency settings.

  • 5

    The study suggests that routine fluid laboratory tests should not be reflexively ordered without relevant clinical scenarios.

Original Source(s)

Related Content